Premium Phosphosite-Specific 7TM Antibodies
Novel Tools for Your GPCR Research
Select Your Country of Delivery below

pT339/pS341-GPR132 (phospho-GPR132 Antibody)

NEW
Agonist-induced Threoine339/Serine341 phosphorylation of GPR132
$ 350.00 *

Prices plus VAT plus shipping costs

Ready to ship today,
Delivery time appr. 5-8 days

  • 7TM0128A
  • 100 µl
  • Rabbit
Threonine339/Serine341 (T339/S341) is major phosphorylation site of human GPR132 receptor. The... more

Threonine339/Serine341 (T339/S341) is major phosphorylation site of human GPR132 receptor. The pT339/pS341-GPR132 antibody detects phosphorylation in response to agonists. T339/S341 phosphorylation is likely to be involved in efficient ligand sequestration by GPR132.

  Alternative Names G Protein-coupled Receptor G2A IUPHAR Target ID... more

 

Alternative Names G Protein-coupled Receptor G2A
IUPHAR Target ID  128
UniProt ID  Q9UNW8
Western Blot (WB)  1:1000
Species Reactivity   Human
Host / Isotype Rabbit / IgG
Class Polyclonal
Immunogen A synthetic phosphopeptide derived from human GPR132 around the phosphorylation site of Thr339/Ser341.
Form  Liquid
Purification Antigen affinity chromatography
Storage buffer Dulbecco's PBS, pH 7.4, with 150 mM NaCl, 0.02% sodium azide
Storage conditions short-term 4°C, long-term -20°C
Figure 1. Agonist-induced Threoine339/Serine341 phosphorylation of GPR132.   Upper... more

Figure 1. Agonist-induced Threoine339/Serine341 phosphorylation of GPR132. Upper panel, HEK293 cells transiently expressing the human GPR132-Receptor were either not exposed (vehicle) or exposed to 100 nM of specific GPR132-Receptor agonist 9-HODE for 5 minutes. Cells were lysed and immunoblotted with the anti-pT339/pS341-GPR132 antibody (7TM0128A) at a dilution of 1:1000. Lower panel, blot was stripped and reprobed with an phosphorylation-independent anti-GRP132 antibody to confirm equal loading of the gel.

Read, write and discuss reviews... more
Customer evaluation for "pT339/pS341-GPR132 (phospho-GPR132 Antibody)"
Write an evaluation
Evaluations will be activated after verification.

The fields marked with * are required.

Recently viewed